Cargando…

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study

BACKGROUND: Experimental and clinical evidence suggest that hypoxia in solid tumours reduces their sensitivity to conventional treatment modalities modulating response to ionizing radiation or chemotherapeutic agents. The aim of the present study was to show the feasibility of determining radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagel, Bernd, Reinartz, Patrick, Demirel, Cengiz, Kaiser, Hans J, Zimny, Michael, Piroth, Marc, Pinkawa, Michael, Stanzel, Sven, Asadpour, Branka, Hamacher, Kurt, Coenen, Heinz H, Buell, Ulrich, Eble, Michael J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456976/ https://www.ncbi.nlm.nih.gov/pubmed/16515707 http://dx.doi.org/10.1186/1471-2407-6-51

Ejemplares similares

pO polarography, contrast enhanced color duplex sonography (CDS), [(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
por: Gagel, Bernd, et al.
Publicado: (2007)

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis
por: Piroth, Marc D, et al.
Publicado: (2008)

Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study
por: Gagel, Bernd, et al.
Publicado: (2007)

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

[(18)F]Fluoromisonidazole PET in rectal cancer
por: Puri, Tanuj, et al.
Publicado: (2017)

Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment
por: Pinkawa, Michael, et al.
Publicado: (2009)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET
por: Abdo, Redha-Alla, et al.
Publicado: (2019)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

(18)F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit (18)F-Fluorodeoxyglucose in Oncology Application
por: Li, Xiao-Feng, et al.
Publicado: (2014)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
por: Jagtap, Rajlaxmi, et al.
Publicado: (2019)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

The hot embolus of (18)F-fluorodeoxyglucose
por: Hussain, Riffat Parveen, et al.
Publicado: (2020)

Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients
por: Bourigault, Pauline, et al.
Publicado: (2022)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

Kinetic analysis of dynamic (18)F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
por: Thorwarth, Daniela, et al.
Publicado: (2005)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT
por: Maruyama, Koji, et al.
Publicado: (2021)

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
por: Pinkawa, Michael, et al.
Publicado: (2012)

PET Imaging of Hepatocellular Carcinomas: (18)F-Fluoropropionic Acid as a Complementary Radiotracer for (18)F-Fluorodeoxyglucose
por: Zhao, Jing, et al.
Publicado: (2019)

Herniated Urinary Bladder Detected on (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Scan Imitating as (18)F-Fluorodeoxyglucose Avid Lesion
por: Gupta, Nitin, et al.
Publicado: (2020)

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma
por: Barajas, Ramon F., et al.
Publicado: (2015)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
por: Sabour, Siamak
Publicado: (2017)

Regional (18)F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma
por: Qin, Jianhua, et al.
Publicado: (2022)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

F18 fluorodeoxyglucose uptake in progressive transformation of germinal centres
por: Rehani, B, et al.
Publicado: (2008)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Mechanisms underlying (18)F-fluorodeoxyglucose accumulation in colorectal cancer
por: Kawada, Kenji, et al.
Publicado: (2016)

Determinants of physiological uptake of (18)F-fluorodeoxyglucose in palatine tonsils
por: Birkin, Emily, et al.
Publicado: (2018)

Takayasu arteritis detected by PET/MRI with (18)F-fluorodeoxyglucose
por: Takeishi, Yasuchika, et al.
Publicado: (2018)

Physiologic Testicular Uptake of 18-F Fluorodeoxyglucose in the Indian Population
por: Parida, Girish Kumar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pqgnvj5qjn0oq9nm0n4i4324dn